• calixlifesciences1.png
  • new_banner copy.jpg
  • new_banner copy1.jpg
  • new_banner copy_1.jpg
  • new_banner copy_2.png
  • new_banner copy_3.jpg

 

VodamoxTM LP Eye Drops


 

Composition:

 

Moxifloxacin Hydrochloride BP

 

eq. to Moxifloxacin …..0.5% w/v

 

Loteprednol Etabonate ….0.5% w/v

 

Beanzalkonium Chloride Solution IP ….0.02% v/v

(As preservative)

 

Sterile aqueous buffered vehicle ……q.s.

 

Novel Combination for Ocular Infection & Inflammation.

 


 

 

Moxifloxacin has Superior corneal and aqueous penetration ability.

 

Moxifloxacin is the most potent & least resistant antibiotic due to addition of C-8 methoxy group which increases potency.

 

VodamoxTM LP contains Loteprednol,A novel C-20 ester-based corticosteroid.

 

Loteprednol is retro metabolically designed to offer potent anti-inflammatory efficacy.

 

Loteprednol has lower propensity to increase IOP relative to Prednisolone acetate or Dexamethasone.

 

 


 

 

Indications:

 

Pre & post-operative prophylactic agent in intraocular surgery to prevent Endophthalmitis.

 

Retro metabolically designed to offer potent anti-inflammatory efficacy.

 

Post operative Management

 

Bacterial Conjunctivitis

 

Superficial Keratitis

 

  • Acuvita.jpg
  • brimofine-t.jpg
  • ebri-tab.png
  • fedcef.png
  • flurostar_eye_drops.jpg
  • Gaticheck.jpg
  • lacricool_eye_drops.jpg
  • lavotears_eye.jpg
  • lavotears_gel.jpg
  • lavoters-eye-oentment.png
  • limaclav.png
  • limaclavp-dry-syrup.png
  • limaflam-tab.png
  • lricain.jpg
  • ocunepa_eye_drops.jpg
  • olspore_od.jpg
  • optipred_eye_drops.jpg
  • supervisc.jpg
  • timogold_eye_drops.jpg
  • vodamox-eye-oentment.png
  • vodamox-T.png
  • vodamox_eye_drops.jpg
  • vodamox_lp.jpg
  • vodamox_plus.jpg
  • winsight-tab.png
Powered by : WDSoft